The ability of inosine modifications to modulate miRNA function in highly proliferating cells, including silencing oncogenes and tumor suppressors of various cancers, highlights the therapeutic potential of targeting adenosine deaminases as targets for chemotherapy. The gene discussed is ADA; the disease is cancer.